SE8101421L - Inre salter av sulfooxi-triazinium, pyrimidinium och pyridinium hydroxid - Google Patents

Inre salter av sulfooxi-triazinium, pyrimidinium och pyridinium hydroxid

Info

Publication number
SE8101421L
SE8101421L SE8101421A SE8101421A SE8101421L SE 8101421 L SE8101421 L SE 8101421L SE 8101421 A SE8101421 A SE 8101421A SE 8101421 A SE8101421 A SE 8101421A SE 8101421 L SE8101421 L SE 8101421L
Authority
SE
Sweden
Prior art keywords
triazinium
pyrimidinium
sulfooxi
pyridinium
internal salts
Prior art date
Application number
SE8101421A
Other languages
English (en)
Other versions
SE448876B (sv
Inventor
J M Mccall
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of SE8101421L publication Critical patent/SE8101421L/sv
Publication of SE448876B publication Critical patent/SE448876B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE8101421A 1980-03-10 1981-03-05 Inre salter av sulfoxi-triazinium-, -pyrimidinium- och -pyridiniumhydroxid och sett att framstella dessa SE448876B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/128,995 US4287338A (en) 1980-03-10 1980-03-10 Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts

Publications (2)

Publication Number Publication Date
SE8101421L true SE8101421L (sv) 1981-09-11
SE448876B SE448876B (sv) 1987-03-23

Family

ID=22437996

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8101421A SE448876B (sv) 1980-03-10 1981-03-05 Inre salter av sulfoxi-triazinium-, -pyrimidinium- och -pyridiniumhydroxid och sett att framstella dessa

Country Status (15)

Country Link
US (1) US4287338A (sv)
JP (1) JPS56150066A (sv)
AU (1) AU536166B2 (sv)
BE (1) BE887850A (sv)
CA (1) CA1154761A (sv)
CH (1) CH645626A5 (sv)
DE (1) DE3107583A1 (sv)
FI (1) FI70410C (sv)
FR (1) FR2477541A1 (sv)
GB (1) GB2071092B (sv)
HK (1) HK98088A (sv)
IT (1) IT1142667B (sv)
NL (1) NL8101114A (sv)
SE (1) SE448876B (sv)
ZA (1) ZA811057B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514672A (en) * 1981-02-17 1996-05-07 Bazzano; Gail S. Use of retinoids and compositions containing same for hair growth
US5183817A (en) * 1981-02-17 1993-02-02 Bazzano Gail S Combinations of retinoids and minoxidil-type compounds for hair growth
US4532240A (en) * 1982-09-09 1985-07-30 Warner-Lambert Company Diaminopyrimidines
WO1986004231A1 (en) * 1985-01-25 1986-07-31 The Upjohn Company Pyrimidine sulfates for hair growth
FR2590897B1 (fr) * 1985-12-06 1988-02-19 Kemyos Bio Medical Research Sr Nouveaux derives de 6 amino 1,2-dihydro-1-hydroxy-2-imino-pyrimidine, leur procede de preparation et compositions cosmetiques les renfermant
US4927626A (en) * 1988-10-28 1990-05-22 Devillez Richard L Method for enhancement of unguis growth
FR2651122B1 (fr) * 1989-08-29 1994-10-28 Oreal Compositions destinees a etre utilisees pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives de l'amino-2 pyrimidine oxyde-3 et nouveaux composes derives de l'amino-2 pyrimidine oxyde-3.
GB8929022D0 (en) * 1989-12-22 1990-02-28 Ici Plc Diazine derivatives
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
WO1992008705A1 (en) * 1990-11-14 1992-05-29 The Upjohn Company 5-fluoro-2,4,6-pyrimidinetriamine compounds
FR2671082B1 (fr) * 1990-12-28 1993-04-16 Oreal Agent a plusieurs composants ou kit de preparation de la forme sulfo-conjuguee de composes pyrimidino- ou triazino-n-oxyde et procede de mise en óoeuvre.
FR2677884B1 (fr) * 1991-06-20 1993-07-09 Oreal Composition pour freiner la chute des cheveux a base de pyrimidines n-oxyde trisubstitues ou leurs derives sulfoconjugues, nouveaux composes pyrimidines n-oxyde ou leurs derives sulfoconjugues.
JP4150497B2 (ja) 1997-08-01 2008-09-17 ヴァーテラス・スペシャリティーズ・インコーポレーテッド 超求核性4−置換−ピリジン触媒、及びその調製に有用な方法
EP1850663A4 (en) * 2005-02-22 2008-03-19 Cedars Sinai Medical Center USE OF MINOXIDILSULFATE AS AN ACTIVE AGAINST CANCER
TW200904437A (en) * 2007-02-14 2009-02-01 Janssen Pharmaceutica Nv 2-aminopyrimidine modulators of the histamine H4 receptor
WO2008122378A1 (en) * 2007-04-04 2008-10-16 Ucb Pharma, S.A. Novel pyridine derivatives, processes for preparing them, pharmaceutical compositions thereof
US8470833B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3270014A (en) * 1965-07-01 1966-08-30 Upjohn Co 1, 2-dihydro-1-hydroxy-1, 3, 5-triazines
US3382248A (en) * 1965-11-01 1968-05-07 Upjohn Co 6-amino-4, 5-di(substituted amino)-1, 2-dihydro-1-hydroxy-2-iminopyrimidines
US3464987A (en) * 1966-02-21 1969-09-02 Upjohn Co 1,2-dihydro-1-hydroxy-2-imino-6-(lower alkyl)pyrimidines
US3973016A (en) * 1974-08-05 1976-08-03 Warner-Lambert Company Blood pressure reducing hydroxypyrimidines
US4021562A (en) * 1975-12-08 1977-05-03 Mead Johnson & Company 4-Tertiary-amino-2,6-diaminopyridine 1-oxides

Also Published As

Publication number Publication date
FI810681L (fi) 1981-09-11
ZA811057B (en) 1982-03-31
NL8101114A (nl) 1981-10-01
IT8147976A0 (it) 1981-03-09
GB2071092A (en) 1981-09-16
HK98088A (en) 1988-12-09
CA1154761A (en) 1983-10-04
AU6737181A (en) 1981-09-17
BE887850A (fr) 1981-09-09
FR2477541A1 (fr) 1981-09-11
JPS56150066A (en) 1981-11-20
DE3107583A1 (de) 1982-01-07
SE448876B (sv) 1987-03-23
FR2477541B1 (sv) 1984-06-01
CH645626A5 (de) 1984-10-15
FI70410B (fi) 1986-03-27
FI70410C (fi) 1986-09-19
IT1142667B (it) 1986-10-15
GB2071092B (en) 1983-09-07
JPH0145467B2 (sv) 1989-10-03
US4287338A (en) 1981-09-01
DE3107583C2 (sv) 1989-11-02
AU536166B2 (en) 1984-04-19

Similar Documents

Publication Publication Date Title
SE7603931L (sv) Forfarande for framstellning av nya tetracykliska foreningar
ATE52766T1 (de) 2-oxyimino-3-oxo-buttersaeurederivate und deren herstellungsverfahren.
DE3162445D1 (de) 3-aryloxy-3-phenylpropylamines
LV12313A (lv) Leikotrienu antagonistu pielietojums
IE37916L (en) Trifluoromethylmercaptoacetamido-cephalosporins
PH22520A (en) Heterocyclic compounds having 4-lover alkyl-3-hydroxy-2-lower alkyl phenoxy-lower alkylene-y-group, and process of producing them
ES2094110T3 (es) Piridinsulfonilureas herbicidas.
ATE97406T1 (de) Halopyridone.
ES8500894A1 (es) Procedimiento para preparar sales de acido 5,5'-azobis-salicico.
ES8604922A1 (es) Procedimiento para la preparacion de n-piridilindoles
NO159851C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive svovelsubstituerte fenoxypyridiner.
SE8102337L (sv) Radiomottagare
ES8605507A1 (es) Un compuesto de 3-indolcarboxamida
SE8004319L (sv) Cefalosporinforeningar, sett for framstellning derav samt lekemedel innehallande dess foreningar
SE7607615L (sv) Antiinflammatoriska medel
ES8107203A1 (es) Procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo
FI832519A0 (fi) Farmaceutiska foerfaranden och sammansaettningar
ATE6588T1 (de) Augenwasserpraeparat auf basis von chondroitinsulfat a.
GR76107B (sv)
SE7602840L (sv) Forfarande for framstellning av nikotinsyraamid
DK262685A (da) Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
ES523555A0 (es) Procedimiento para la obtencion de benzoil-(tio)ureas sustituidas.
SE8200515L (sv) Bicykliska foreningar
SE8303435L (sv) Nytt pyrazolopyridinderivat
FI832520A0 (fi) Farmaceutiska foerfaranden och sammansaettningar

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8101421-9

Effective date: 19941010

Format of ref document f/p: F